UA84896C2 - Производные гидронопола как агонисты человеческих рецепторов orl1 - Google Patents
Производные гидронопола как агонисты человеческих рецепторов orl1Info
- Publication number
- UA84896C2 UA84896C2 UAA200607374A UAA200607374A UA84896C2 UA 84896 C2 UA84896 C2 UA 84896C2 UA A200607374 A UAA200607374 A UA A200607374A UA A200607374 A UAA200607374 A UA A200607374A UA 84896 C2 UA84896 C2 UA 84896C2
- Authority
- UA
- Ukraine
- Prior art keywords
- agonists
- receptors
- hydronopol
- derivatives
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
Изобретение касается группы производных гидронопола, которые являются агонистами человеческих рецепторов ORL1 (ноцицептина).Изобретение также касается способов получения этих соединений, фармацевтических композиций, которые содержат фармакологически активное количество, по крайней мере, одного из этих новых производных гидронопола как действующего вещества, а также применения этих фармацевтических композиций для лечения расстройств, связанных с рецепторами ORL1.Изобретение касается соединений общей формулы (1),где радикалы имеют значения, которые приведены в описании.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03104662 | 2003-12-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA84896C2 true UA84896C2 (ru) | 2008-12-10 |
Family
ID=34924140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200607374A UA84896C2 (ru) | 2003-12-12 | 2004-12-09 | Производные гидронопола как агонисты человеческих рецепторов orl1 |
Country Status (14)
Country | Link |
---|---|
US (1) | US7241770B2 (ru) |
EP (1) | EP1694675A2 (ru) |
JP (1) | JP2007513922A (ru) |
CN (1) | CN1890238A (ru) |
AR (1) | AR046756A1 (ru) |
AU (1) | AU2004298436A1 (ru) |
BR (1) | BRPI0417161A (ru) |
CA (1) | CA2547633A1 (ru) |
MX (1) | MXPA06005675A (ru) |
RU (1) | RU2351600C2 (ru) |
TW (1) | TW200522949A (ru) |
UA (1) | UA84896C2 (ru) |
WO (1) | WO2005058890A2 (ru) |
ZA (1) | ZA200604791B (ru) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR045843A1 (es) * | 2003-10-03 | 2005-11-16 | Solvay Pharm Bv | Derivados de bencimidazolonas y quinazolinonas sustituidas con hidronopol como agonistas en receptores orl 1 humanos |
CA2630492C (en) * | 2005-12-05 | 2015-04-14 | Incyte Corporation | Spiro-lactam compounds |
US20070299072A1 (en) * | 2006-06-20 | 2007-12-27 | Wyeth | Kv1.5 potassium channel inhibitors |
RU2458902C1 (ru) * | 2011-07-08 | 2012-08-20 | Учреждение Российской академии наук Институт катализа им. Г.К. Борескова Сибирского отделения РАН | Способ получения миртанола |
US9963458B2 (en) | 2012-12-27 | 2018-05-08 | Purdue Pharma L.P. | Indole and indoline-type piperidine compounds and uses thereof |
US9090618B2 (en) | 2012-12-27 | 2015-07-28 | Purdue Pharma L.P. | Substituted benzimidazole-type piperidine compounds and uses thereof |
US9040533B2 (en) | 2012-12-27 | 2015-05-26 | Purdue Pharma L.P. | Oxime-substituted-quinoxaline-type piperidine compounds as ORL-1 modulators |
WO2014102590A1 (en) | 2012-12-27 | 2014-07-03 | Purdue Pharma L.P. | Substituted piperidin-4-amino-type compounds and uses thereof |
WO2014102589A1 (en) | 2012-12-27 | 2014-07-03 | Purdue Pharma L.P. | Quinazolin-4(3h)-one-type piperidine compounds and uses thereof |
WO2015037665A1 (ja) | 2013-09-12 | 2015-03-19 | 信越化学工業株式会社 | β-シクロラバンジュラール及びその誘導体の製造方法 |
US20160221923A1 (en) * | 2013-09-12 | 2016-08-04 | Shin-Etsu Chemical Co., Ltd. | Method for producing cyclolavandulol and derivative thereof |
CN104557653A (zh) * | 2014-12-31 | 2015-04-29 | 大连联化化学有限公司 | 7-甲基-氮杂-二环[4,1,0]庚烷的制备方法 |
UA121775C2 (uk) | 2015-07-31 | 2020-07-27 | Пфайзер Інк. | 1,1,1-трифтор-3-гідроксипропан-2-ілкарбаматні похідні та 1,1,1-трифтор-4-гідроксибутан-2-ілкарбаматні похідні як інгібітори magl |
US10112924B2 (en) | 2015-12-02 | 2018-10-30 | Astraea Therapeutics, Inc. | Piperdinyl nociceptin receptor compounds |
EP3484908A4 (en) | 2016-07-15 | 2020-04-08 | AM Chemicals Llc | NON-NUCLEOSIDIC SOLID CARRIERS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTID SYNTHESIS |
CA3050625C (en) | 2017-01-20 | 2021-07-20 | Pfizer Inc. | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as magl inhibitors |
EP3571202B1 (en) | 2017-01-23 | 2021-06-30 | Pfizer Inc. | Heterocyclic spiro compounds as magl inhibitors |
IT201800007580A1 (it) * | 2018-07-27 | 2020-01-27 | Maria Cecilia Hospital Spa | Composti 1,3,8-triazaspiro e loro uso come medicamenti |
CN115124441B (zh) * | 2022-06-30 | 2024-04-02 | 南京林业大学 | 一类诺卜酸酰肼类化合物的制备方法和产品及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6262066B1 (en) | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
DE69923744T2 (de) | 1998-10-23 | 2006-02-23 | Pfizer Inc. | 1,3,8-Triazaspiro[4,5] decanon Verbindungen als orl1-receptor Agonisten |
JP2000169476A (ja) | 1998-12-09 | 2000-06-20 | Banyu Pharmaceut Co Ltd | 4−オキソイミダゾリジン−5−スピロ−含窒素複素環式化合物 |
EP1537110B1 (en) | 1999-12-06 | 2007-01-17 | Euro-Celtique, S.A. | Triazospiro compounds having nociceptin receptor affinity |
WO2002083673A1 (en) | 2001-04-10 | 2002-10-24 | Ortho-Mcneil Pharmaceutical, Inc. | 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders |
EA009369B1 (ru) | 2002-09-09 | 2007-12-28 | Янссен Фармацевтика, Н.В. | Производные гидроксизамещенного 1,3,8-триазинспиро[4,5]декан-4-она, полезные для лечения расстройств, опосредованных orl-рецептором |
-
2004
- 2004-12-07 AR ARP040104561A patent/AR046756A1/es not_active Application Discontinuation
- 2004-12-09 BR BRPI0417161-6A patent/BRPI0417161A/pt not_active IP Right Cessation
- 2004-12-09 WO PCT/EP2004/053373 patent/WO2005058890A2/en active Application Filing
- 2004-12-09 TW TW093138116A patent/TW200522949A/zh unknown
- 2004-12-09 CA CA002547633A patent/CA2547633A1/en not_active Abandoned
- 2004-12-09 UA UAA200607374A patent/UA84896C2/ru unknown
- 2004-12-09 EP EP04804747A patent/EP1694675A2/en not_active Withdrawn
- 2004-12-09 JP JP2006543547A patent/JP2007513922A/ja not_active Withdrawn
- 2004-12-09 US US11/007,255 patent/US7241770B2/en not_active Expired - Fee Related
- 2004-12-09 RU RU2006124856/04A patent/RU2351600C2/ru active
- 2004-12-09 MX MXPA06005675A patent/MXPA06005675A/es active IP Right Grant
- 2004-12-09 CN CNA2004800365151A patent/CN1890238A/zh active Pending
- 2004-12-09 AU AU2004298436A patent/AU2004298436A1/en not_active Abandoned
-
2006
- 2006-06-09 ZA ZA200604791A patent/ZA200604791B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA06005675A (es) | 2006-08-17 |
US7241770B2 (en) | 2007-07-10 |
AR046756A1 (es) | 2005-12-21 |
CA2547633A1 (en) | 2005-06-30 |
RU2006124856A (ru) | 2008-01-20 |
WO2005058890A3 (en) | 2005-08-18 |
US20050131004A1 (en) | 2005-06-16 |
ZA200604791B (en) | 2008-07-30 |
TW200522949A (en) | 2005-07-16 |
AU2004298436A1 (en) | 2005-06-30 |
CN1890238A (zh) | 2007-01-03 |
WO2005058890A2 (en) | 2005-06-30 |
BRPI0417161A (pt) | 2007-03-06 |
JP2007513922A (ja) | 2007-05-31 |
EP1694675A2 (en) | 2006-08-30 |
RU2351600C2 (ru) | 2009-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA84896C2 (ru) | Производные гидронопола как агонисты человеческих рецепторов orl1 | |
TW200517388A (en) | Thiazole derivatives as cannabinoid receptor modulators | |
SE0302760D0 (sv) | New compounds | |
IL176546A0 (en) | Imidazoline derivatives having cb1-antagonistic activity | |
TN2009000180A1 (en) | NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF | |
HK1084941A1 (en) | Compounds and their use | |
TW200621737A (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
HK1076605A1 (en) | Formulations | |
HK1094425A1 (en) | Substituted 2-aminotetralines for the preventive treatment of parkinson's disease | |
WO2006011050A3 (en) | Pyridine derivatives | |
MXPA05010859A (es) | Antagonistas mchr1 heterociclicos. | |
EP2202222A3 (en) | Indene derivatives, their preparation and use as medicaments | |
WO2004089366A8 (en) | Bicyclic compounds as nr2b receptor antagonists | |
ES2193875A1 (es) | Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos. | |
TW200519101A (en) | Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors | |
WO2005060959A8 (en) | Pyrazole derivatives and use thereof as orexin receptor antagonists | |
TW200519102A (en) | Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors | |
TW200514785A (en) | Hexa- and octahydro-pyrido[1,2-a]pyrazine derivatives with NK1 antagonistic activity | |
MX2009005242A (es) | Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo. | |
MX2007005824A (es) | Agonistas y antagonistas del receptor de somatostatina. | |
NO20063138L (no) | Hydronopolderivater som agonister i human ORL1 receptorer | |
NO20061966L (no) | Bicyklo[3.1.1.]heptansubstituerte benzimidazolon- og kinazolinonderivater som agonister for humane ORL1 reseptorer | |
NO20061836L (no) | Heksa- og oktahydro-pyndo[1,2-a]pyrazinderlvater med NK1 antagonistisk aktivitet |